About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Glaxosmithkline Pharmaceuticals Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
500660
ISIN Demat
INE159A01016
Book Value
128.02
NSE Code
GLAXO
Dividend Yield %
1.95
Market Cap
467331.96
P/E
49.60
EPS
55.61
Face Value
10
BSE
NSE
17-Sep-2025 12:13
BSE
NSE
NSE F & O
17-Sep-2025 12:04
BSE
NSE
NSE F & O
Last Price
2767.00
Net Change
28.5
% Change
1.04%
Prev.Close
2738.50
Open
2751.95
High
2767.20
Low
2734.55
Volume
1783
Last Price
2765.00
Net Change
26.8
% Change
0.98%
Prev.Close
2738.20
Open
2742.00
High
2767.80
Low
2732.30
Volume
28891
Value
4933561
Best Buy
2756.95
Best Sell
2762.40
Best Quantity
37
Sell Quantity
1
Today's Range
2767.20
52-Week High
3515.95
52-Week Low
1924.30
Value
79883615
Best Buy
2764.00
Best Sell
2764.30
Best Quantity
1
Sell Quantity
21
Today's Range
2767.80
52-Week High
3515.70
52-Week Low
1921.00
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
37
Price
2756.95
Quantity
1
Price
2762.40
Best Bid
Best Offer
Quantity
1
Price
2764.00
Quantity
21
Price
2764.30
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Bonus
1 : 1
11-Sep-18
Book Closure
15-Jul-19
22-Jul-19
Dividend
420 %
30-May-25
Company News
26-08-2025
Glaxosmithkline Pharmaceu...
25-08-2025
Glaxosmithkline Pharmaceu...
25-08-2025
GlaxoSmithKline Pharmace...
25-08-2025
Glaxosmithkline Pharmaceu...
04-08-2025
GlaxoSmithKline Pharmaceu...
01-08-2025
Clarification sought fro...
28-07-2025
GlaxoSmithKline Pharmaceu...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.